Article
Oncology
Madelon Dijkstra, Sanne Nieuwenhuizen, Robbert S. Puijk, Florentine E. F. Timmer, Bart Geboers, Evelien A. C. Schouten, Jip Opperman, Hester J. Scheffer, Jan J. J. de Vries, Kathelijn S. Versteeg, Birgit Lissenberg-Witte, Martijn R. Meijerink, Monique Petrousjka van den Tol
Summary: This study found that adding neoadjuvant chemotherapy before repeat local treatment for colorectal liver metastases did not improve survival rates, recurrence rates, or impact complications and hospital stay duration. The results do not support routine use of neoadjuvant chemotherapy before repeat local treatment.
Review
Oncology
Madelon Dijkstra, Sanne Nieuwenhuizen, Robbert S. Puijk, Bart Geboers, Florentine E. F. Timmer, Evelien A. C. Schouten, Hester J. Scheffer, Jan J. J. de Vries, Johannes C. F. Ket, Kathelijn S. Versteeg, Martijn R. Meijerink, M. Petrousjka van den Tol
Summary: The potential additive value of neoadjuvant chemotherapy prior to repeat local treatment for recurrent colorectal liver metastases remains unclear, with conflicting results from limited studies. Recommendations for routine use of neoadjuvant chemotherapy are not supported by the inconclusive findings of this meta-analysis, highlighting the need for further investigation in future randomized controlled trials.
Article
Oncology
Mizuki Ninomiya, Yasunori Emi, Takashi Motomura, Takahiro Tomino, Tomohiro Iguchi, Hiroto Kayashima, Noboru Harada, Hideaki Uchiyama, Takashi Nishizaki, Hidefumi Higashi, Hiroyuki Kuwano
Summary: The study suggests that patients with synchronous and Grade B/C colorectal liver metastases may benefit from neoadjuvant chemotherapy before surgery.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
(2021)
Article
Oncology
Kosuke Ono, Tomoyuki Abe, Akihiko Oshita, Yusuke Sumi, Takuya Yano, Hiroshi Okuda, Manabu Kurayoshi, Tsuyoshi Kobayashi, Hideki Ohdan, Toshio Noriyuki, Masahiro Nakahara
Summary: Our study revealed that neoadjuvant chemotherapy and Beppu's nomogram score are independent risk factors for recurrence in patients with resectable CRLM. Upfront hepatectomy without neoadjuvant chemotherapy can be considered for treating resectable CRLM. Recipients of neoadjuvant chemotherapy had higher incidence of lymph node metastasis and vascular invasion compared to non-recipients.
WORLD JOURNAL OF SURGICAL ONCOLOGY
(2021)
Article
Gastroenterology & Hepatology
Fumitoshi Hirokawa, Masaki Ueno, Takuya Nakai, Masaki Kaibori, Takeo Nomi, Hiroya Iida, Shogo Tanaka, Koji Komeda, Shinya Hayami, Hisashi Kosaka, Daisuke Hokuto, Shoji Kubo, Kazuhisa Uchiyama
Summary: This study compared the effectiveness of neoadjuvant chemotherapy and upfront surgery for resectable colorectal liver metastasis patients and found that upfront surgery group had a higher overall survival rate, thus suggesting that these patients should undergo upfront surgery.
JOURNAL OF GASTROINTESTINAL SURGERY
(2022)
Article
Oncology
Feng-Lin Chen, Yan-Yan Wang, Wei Liu, Bao-Cai Xing
Summary: This study assessed the efficacy of neoadjuvant chemotherapy (NAC) in resectable colorectal liver metastases (CRLM) patients with high clinical risk scores (CRS) after balancing baseline characteristics by propensity score matching (PSM). The results showed that NAC improved overall survival (OS) and resulted in shorter postoperative hospital stays.
FRONTIERS IN ONCOLOGY
(2022)
Article
Oncology
Yaoqun Wang, Ningyuan Wen, Xianze Xiong, Jiong Lu, Bei Li, Nansheng Cheng
Summary: This study retrospectively analyzed patients with synchronous colorectal cancer liver metastases who underwent neoadjuvant chemotherapy followed by surgery. The patients were divided into two groups based on the timing of surgery after chemotherapy, and the perioperative and oncologic outcomes were compared. The results showed that surgery within 4-6 weeks after neoadjuvant chemotherapy had fewer postoperative complications but lower long-term survival rates and disease-free survival rates, indicating that early surgery may still be a better choice for patients with synchronous colorectal cancer liver metastases.
WORLD JOURNAL OF SURGICAL ONCOLOGY
(2023)
Article
Surgery
Kosuke Kobayashi, Yosuke Inoue, Yuki Kitano, Shoki Sato, Atsushi Oba, Yoshihiro Ono, Takafumi Sato, Hiromichi Ito, Yoshihiro Mise, Akio Saiura, Yu Takahashi
Summary: A predictive model for conversion surgery was developed and the long-term outcomes of patients with technically unresectable colorectal liver metastases were evaluated. Patients who underwent conversion surgery had significantly higher median overall survival compared to those who did not. The predictive model for conversion surgery was constructed using several predictive factors. Patients were graded according to their scores, and those in Grade A had significantly better overall survival than Grade B and C patients.
Article
Oncology
Kiyohiko Omichi, Yosuke Inoue, Yoshihiro Mise, Atsushi Oba, Yoshihiro Ono, Takafumi Sato, Hiromichi Ito, Yu Takahashi, Akio Saiura
Summary: The optimal surgical strategy for patients with multiple colorectal liver metastases remains unclear. This study compared the outcomes of one-step hepatectomy (OSH) and two-stage hepatectomy (TSH) in treating these patients. The results showed no significant difference in treatment outcomes between the two surgical approaches.
ANNALS OF SURGICAL ONCOLOGY
(2022)
Article
Gastroenterology & Hepatology
Da Xu, Hai-Bin Zhu, Yan-Yan Wang, Ke-Min Jin, Xiao-Luan Yan, Juan Li, Kun Wang, Bao-Cai Xing
Summary: Perioperative second-line chemotherapy can significantly prolong the survival of patients with liver metastases from colorectal cancer during or early after adjuvant chemotherapy.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE
(2022)
Review
Oncology
Gabriel D. Ivey, Fabian M. Johnston, Nilofer S. Azad, Eric S. Christenson, Kelly J. Lafaro, Christopher R. Shubert
Summary: Colorectal cancer is one of the most common types of cancer, and at least half of patients diagnosed with it will develop metastatic liver disease. Surgical resection of colorectal liver metastases is considered potentially curative, but it is underutilized despite the availability of various operative strategies. Differing views on resectability may contribute to this underutilization.
Article
Surgery
Takeshi Takamoto, Satoshi Nara, Daisuke Ban, Takahiro Mizui, Yoshiki Murase, Minoru Esaki, Kazuaki Shimada, Takuya Hashimoto, Masatoshi Makuuchi
Summary: The study aimed to assess the prognostic benefit of neoadjuvant chemotherapy (NAC) for resectable advanced colorectal liver metastases (CRLM) and search for optimal indication by establishing an objective definition of biologically borderline resectable (bBR) CRLM. The study found that NAC did not enhance the prognostic impact of liver resection for bBR-CRLM, except for a limited number of optimal candidates experiencing the Biological Conversion.
WORLD JOURNAL OF SURGERY
(2023)
Review
Medicine, General & Internal
Emmanouil Georgilis, Maria Gavriatopoulou, Diamantis I. Tsilimigras, Panagiotis Malandrakis, Theodosios Theodosopoulos, Ioannis Ntanasis-Stathopoulos
Summary: Although surgical resection is the gold standard for resectable colorectal cancer liver metastases (CRLMs), the management after surgery remains controversial. This systematic review aimed to evaluate the efficacy, tolerability, and safety profile of different chemotherapeutic agents used as adjuvant treatment after surgical resection of CRLMs. The results showed that adjuvant therapy improved regression-free survival (RFS) and disease-free survival (DFS), but did not significantly prolong overall survival (OS), and the choice of therapeutic strategy did not have a differential impact on patient outcomes. More high-quality clinical trials are needed to determine which patients would benefit the most from adjuvant therapy after surgery for CRLMs.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Surgery
G. E. Wensink, Karen Bolhuis, Marloes A. G. Elferink, Remond J. A. Fijneman, Onno Kranenburg, Inne H. M. Borel Rinkes, Miriam Koopman, Rutger-Jan Swijnenburg, Geraldine R. Vink, Jeroen Hagendoorn, Cornelis J. A. Punt, Jeanine M. L. Roodhart, Sjoerd G. Elias
Summary: A prediction model for early extrahepatic recurrence (EHR) after local treatment of colorectal liver metastases (CRLMs) has been developed, which can predict 6-month EHR using routine clinical information and assist in clinical decision-making.
BRITISH JOURNAL OF SURGERY
(2023)
Article
Oncology
Lily V. Saadat, Thomas Boerner, Debra A. Goldman, Mithat Gonen, Timothy L. Frankel, Efsevia Vakiani, T. Peter Kingham, William R. Jarnagin, Alice C. Wei, Kevin C. Soares, David B. Solit, Michael I. D'Angelica
Summary: RAS mutations are prognostic for mCRC patients. KRAS exon 3/4 mutations are rare and may be associated with a more favorable prognosis, but the difference in oncologic outcomes based on the mutated exon appears to be smaller than previously reported.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Article
Surgery
Matteo Serenari, Jacopo Lenzi, Alessandro Cucchetti, Federica Cipriani, Matteo Donadon, Francesco Ardito, Federico Fazio, Daniele Nicolini, Maurizio Iaria, Simone Famularo, Pasquale Perri, Luca Ansaloni, Matteo Zanello, Quirino Lai, Simone Conci, Sarah Molfino, Cecilia Ferrari, Paola Germani, Mauro Zago, Maurizio Romano, Giuseppe Zimmitti, Adelmo Antonucci, Luca Fumagalli, Albert Troci, Valentina Ferraro, Riccardo Memeo, Michele Crespi, Marco Chiarelli, Giorgio A. Ercolani, Mohamed A. Hilal, Giacomo Zanus, Enrico Pinotti, Paola Tarchi, Guido Griseri, Gian Luca Baiocchi, Andrea Ruzzenente, Massimo Rossi, Elio Jovine, Marcello Maestri, Gian Luca Grazi, Fabrizio Romano, Raffaele Dalla Valle, Matteo Ravaioli, Marco Vivarelli, Alessandro Ferrero, Felice Giuliante, Guido Torzilli, Luca Aldrighetti, Matteo Cescon
Summary: This study aimed to evaluate the impact of a liver transplantation program on the outcomes of resectable hepatocellular carcinoma. The presence of a liver transplantation program was associated with decreased posthepatectomy liver failure rates and increased likelihood of salvage liver transplantation in case of tumor recurrence, which had a positive impact on postoperative survival.
Article
Gastroenterology & Hepatology
Carlo Sposito, Francesca Ratti, Alessandro Cucchetti, Francesco Ardito, Andrea Ruzzenente, Stefano Di Sandro, Marianna Maspero, Giorgio Ercolani, Fabrizio Di Benedetto, Alfredo Guglielmi, Felice Giuliante, Luca Aldrighetti, Vincenzo Mazzaferro
Summary: This study aimed to determine whether lymphadenectomy improves long-term outcomes in patients with clinically node-negative intrahepatic cholangiocarcinoma (iCCA). The results showed that adequate lymphadenectomy significantly improved survival outcomes for patients with clinically node-negative iCCA who were found to be node-positive at pathology. Therefore, routine use of adequate lymphadenectomy is recommended for patients with clinically node-negative iCCA.
JOURNAL OF HEPATOLOGY
(2023)
Article
Gastroenterology & Hepatology
Giammauro Berardi, Francesca Ratti, Carlo Sposito, Martina Nebbia, Daniel M. D'Souza, Franco Pascual, Epameinondas Dogeas, Samer Tohme, Francesco E. D'Amico, Remo Alessandris, Ilaria Simonelli, Celeste Del Basso, Nadia Russolillo, Amika Moro, Guido Fiorentini, Matteo Serenari, Fernando Rotellar, Giuseppe Zimmitti, Simone Famularo, Tommy Ivanics, Daniel Hoffman, Edwin Onkendi, Yasmin Essaji, Santiago Lopez Ben, Celia Caula, Gianluca Rompianesi, Asmita Chopra, Mohammed Abu Hilal, Guido Torzilli, Gonzalo Sapisochin, Carlos Corvera, Adnan Alseidi, Scott Helton, Roberto I. Troisi, Kerri Simo, Claudius Conrad, Matteo Cescon, Sean Cleary, Choon H. D. Kwon, Alessandro Ferrero, Giuseppe M. Ettorre, Umberto Cillo, David Geller, Daniel Cherqui, Pablo E. Serrano, Cristina Ferrone, Vincenzo Mazzaferro, Luca Aldrighetti, T. Peter Kingham
Summary: A predictive model for postoperative major morbidity after liver resection in patients with metabolic syndrome and HCC has been developed and validated, identifying obesity, diabetes, ischemic heart disease, and other factors as risk factors for major complications.
Article
Chemistry, Multidisciplinary
Riccardo Biondi, Matteo Renzulli, Rita Golfieri, Nico Curti, Gianluca Carlini, Claudia Sala, Enrico Giampieri, Daniel Remondini, Giulio Vara, Arrigo Cattabriga, Maria Adriana Cocozza, Luigi Vincenzo Pastore, Nicolo Brandi, Antonino Palmeri, Leonardo Scarpetti, Gaia Tanzarella, Matteo Cescon, Matteo Ravaioli, Gastone Castellani, Francesca Coppola
Summary: This study evaluated the possibility of using radiomic features to predict the presence/absence of microvascular invasion (MVI) in hepatocellular carcinoma liver tumors. The results showed that radiomic features from the tumor region of contrast-enhanced computed tomography (CECT) images had good predictive performance for MVI.
APPLIED SCIENCES-BASEL
(2023)
Review
Medicine, General & Internal
Cristiana Laici, Amedeo Bianchini, Noemi Miglionico, Niccolo Bambagiotti, Giovanni Vitale, Guido Fallani, Matteo Ravaioli, Antonio Siniscalchi
Summary: Liver transplantation is the gold standard treatment for end-stage liver disease, and the use of ECMO and CRRT support during the peri-transplantation period has shown positive outcomes in managing life-threatening complications. This retrospective study evaluated three clinical cases of planned ECMO support strategies in liver transplantation and found that all three patients had successful outcomes. The use of ECMO and CRRT support in peri-transplantation allows patients to overcome contraindications and undergo liver transplantation successfully.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Biochemistry & Molecular Biology
Cristina Morsiani, Salvatore Collura, Federica Sevini, Erika Ciurca, Valentina Rosa Bertuzzo, Claudio Franceschi, Gian Luca Grazi, Matteo Cescon, Miriam Capri
Summary: The study aimed to evaluate the changes in circulating microRNA (c-miR) in the blood of liver transplant recipients before and after transplantation, and to correlate their levels with gold standard biomarkers and outcomes such as rejection or complications. The results showed that c-miR changes were associated with follow-up time, and miR-122-5p, miR-92a-3p, and miR-18a-5p exhibited the same trend after transplantation, with an increase in their levels in patients with complications. Compared to changes in standard haemato-biochemical parameters, the importance of c-miRs as potential noninvasive biomarkers for monitoring patient outcomes was confirmed.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Pathology
Francesco Vasuri, Mattia Riefolo, Matteo Ravaioli, Matteo Cescon, Gianandrea Pasquinelli, Giuliana Germinario, Antonia D'Errico
Summary: This study aimed to validate the impact of graft histology on transplant outcome and found that grafts with portal fibrosis stage = 3 had a higher incidence of early allograft dysfunction and 6-month dysfunction. Portal inflammation and lobular fibrosis were also correlated with post-transplant kidney function and graft survival. However, the use of HOPE significantly reduced the risk factor of portal inflammation on graft survival.
PATHOLOGY RESEARCH AND PRACTICE
(2023)
Article
Surgery
Matteo Serenari, Francesca Ratti, Nicola Guglielmo, Matteo Zanello, Federico Mocchegiani, Jacopo Lenzi, Michele Colledan, Vincenzo Mazzaferro, Umberto Cillo, Alessandro Ferrero, Matteo Cescon, Fabrizio Di Benedetto, Marco Massani, Gianluca Grazi, Raffaele Dalla Valle, Marco Vivarelli, Giuseppe Maria Ettorre, Luca Aldrighetti, Elio Jovine
Summary: This study analyzed the trend and influencing factors of ALPPS in Italy. It was found that the use of ALPPS has slightly declined, but the use of minimally invasive techniques has increased, leading to a reduced 90-day mortality rate. Post-hepatectomy liver failure (PHLF) still remains an unresolved issue.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
Article
Medicine, General & Internal
Domenico Pinelli, Matteo Cescon, Matteo Ravaioli, Flavia Neri, Annalisa Amaduzzi, Matteo Serenari, Greta Carioli, Antonio Siniscalchi, Michele Colledan
Summary: Surgical strategies for graft portal vein flow restoration vary, and the Yerdel grading is commonly used to determine the prognosis of patients with portal vein thrombosis undergoing liver transplantation. The study compared termino-terminal portal vein anastomosis (TTA) and bypass reconstruction for complex PVT patients and found that the bypass group had a higher mortality rate. Yerdel grade did not affect the rate of early complications, suggesting that surgical approach and PVT extension should be considered in PVT management.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Oncology
Francesco Fiz, Noemi Rossi, Serena Langella, Andrea Ruzzenente, Matteo Serenari, Francesco Ardito, Alessandro Cucchetti, Teresa Gallo, Giulia Zamboni, Cristina Mosconi, Luca Boldrini, Mariateresa Mirarchi, Stefano Cirillo, Mario De Bellis, Ilaria Pecorella, Nadia Russolillo, Martina Borzi, Giulio Vara, Caterina Mele, Giorgio Ercolani, Felice Giuliante, Matteo Ravaioli, Alfredo Guglielmi, Alessandro Ferrero, Martina Sollini, Arturo Chiti, Guido Torzilli, Francesca Ieva, Luca Vigano
Summary: This multicenter study demonstrates that radiomic data extracted from preoperative computed tomography scans have a strong association with tumor grading and microscopic vascular invasion in patients with intrahepatic cholangiocarcinoma. The combination of radiomic and clinical data improves the accuracy of prediction, marking a step towards precision medicine in intrahepatic cholangiocarcinoma patients.
Article
Surgery
L. Solaini, D. Cavaliere, G. Rocco, A. Avanzolini, D. Di Pietrantonio, G. Ercolani
Summary: The study aims to analyze the learning curve of each step of robotic transabdominal pre-peritoneal inguinal hernia repair (rTAPP) in two surgeons with varying degrees of expertise with the robotic platform but no experience with laparoscopic hernia repair. It was found that there was a learning phase followed by a gradual improvement in operative time and outcomes. The learning phase of rTAPP surgery may vary between 20 and 35 cases, depending on the surgeon's experience in robotic surgery.
Article
Surgery
Anne-Marleen van Keulen, Stefan Buettner, Joris Erdmann, Johann Pratschke, Francesca Ratti, William R. Jarnagin, Andreas A. Schnitzbauer, Hauke Lang, Andrea Ruzzenente, Silvio Nadalin, Matteo Cescon, Baki Topal, Pim B. Olthof, Bas Groot Koerkamp
Summary: Two preoperative prognostic models were created to predict 90-day mortality and survival after major liver resection for perihilar cholangiocarcinoma. The results showed that 17.6% of patients were suitable for surgical treatment, 26.8% of patients were not suitable for surgical treatment, and 66.2% of patients were in the intermediate risk group. These prognostic models can help identify patients with resectable perihilar cholangiocarcinoma who are unlikely to benefit from surgical resection.
BRITISH JOURNAL OF SURGERY
(2023)
Article
Surgery
Andrea Laurenzi, Giovanni Brandi, Federica Greco, Enrico Prosperi, Andrea Palloni, Matteo Serenari, Giorgio Frega, Matteo Ravaioli, Alessandro Rizzo, Matteo Cescon
Summary: Repeated surgical resection for recurrent cholangiocarinoma is a feasible treatment option that can improve survival in patients. This study evaluated the long-term outcomes of patients who underwent repeated resection for recurrent CCA and found that it can lead to good postoperative results and increased survival.
LANGENBECKS ARCHIVES OF SURGERY
(2023)
Article
Cardiac & Cardiovascular Systems
Amedeo Bianchini, Cristiana Laici, Martina Bordini, Matteo Bianchin, Catalin Iustin Ioan Silvas, Matteo Cescon, Matteo Ravaioli, Giovanni Vitale, Antonio Siniscalchi
Summary: This article mainly introduces the application of TEE in liver transplantation, especially in the case of using VVB, as an important tool for guiding treatment. TEE has multiple potential uses in guiding catheterization and optimal cannula positioning, managing Patent Foramen Ovale, assisting in anticoagulation therapy, and evaluating bypass efficiency and correcting hypovolemia.
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE
(2023)
Article
Oncology
Diego de Miguel-Perez, Edward M. Pickering, Umberto Malapelle, William Grier, Francesco Pepe, Pasquale Pisapia, Gianluca Russo, Joseph A. Pinto, Alessandro Russo, Giancarlo Troncone, Melissa J. Culligan, Katherine A. Scilla, Ranee Mehra, Pranshu Mohindra, Oscar Arrieta, Andres F. Cardona, Marzia Del Re, Ashutosh Sachdeva, Fred R. Hirsch, Andrea Wolf, Joseph S. Friedberg, Christian Rolfo
Summary: In this study, genetic alterations in resectable pleural mesothelioma tissues and blood samples were analyzed, and it was found that high tissue tumor mutational burden, tissue median minor allele frequency, blood tumor mutational burden, and specific mutations were correlated with outcomes in patients with resected PM. These findings suggest that molecular profiling could help identify longer survivors in patients with resected PM.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Davide Melisi, Camilla Zecchetto, Valeria Merz, Giuseppe Malleo, Luca Landoni, Alberto Quinzii, Simona Casalino, Federica Fazzini, Marina Gaule, Camilla Pesoni, Luca Casetti, Alessandro Esposito, Giovanni Marchegiani, Cristiana Piazzola, Mirko D'Onofrio, Riccardo de Robertis, Armando Gabbrielli, Laura Bernardoni, Stefano F. Crino, Silvia Pietrobono, Claudio Luchini, Camillo Aliberti, Guido Martignoni, Stefano Milleri, Giovanni Butturini, Aldo Scarpa, Roberto Salvia, Claudio Bassi
Summary: This study evaluated the safety and activity of liposomal irinotecan in the perioperative treatment of resectable pancreatic ductal adenocarcinoma (rPDAC) patients. The results showed that NALIRIFOX has manageable and active outcomes, and should be further investigated in randomized trials comparing it to standard upfront surgery followed by adjuvant therapy.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Eric Jonasch, Todd M. Bauer, Kyriakos P. Papadopoulos, Elizabeth R. Plimack, Jaime R. Merchan, David F. Mcdermott, M. Dror Michaelson, Leonard J. Appleman, Ananya Roy, Rodolfo F. Perini, Yanfang Liu, Toni K. Choueiri
Summary: After a median follow-up of 41.2 months, belzutifan monotherapy demonstrated durable antitumor activity in patients with advanced ccRCC and acceptable safety.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Patricia A. H. Hamers, Geraldine R. Vink, Marloes A. G. Elferink, Leon M. G. Moons, Cornelis J. A. Punt, Anne M. May, Miriam Koopman
Summary: Screen-detection of the primary tumor is associated with longer overall survival after metachronous metastasis.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Camilla Nero, Nicolo Bizzarri, Stefano Di Berardino, Francesca Sillano, Giuseppe Vizzielli, Francesco Cosentino, Virginia Vargiu, Pierandrea De Iaco, Anna Myriam Perrone, Enrico Vizza, Benito Chiofalo, Stefano Uccella, Fabio Ghezzi, Luigi Carlo Turco, Giacomo Corrado, Diana Giannarelli, Tina Pasciuto, Gian Franco Zannoni, Anna Fagotti, Giovanni Scambia
Summary: This study evaluates the sensitivity and specificity of sentinel-lymph-node mapping compared to systematic lymphadenectomy in detecting lymph node metastasis in early stage ovarian cancer. The results show that sentinel-lymph-node mapping did not reach the expected sensitivity, but ultra-staging protocol improved the accuracy of diagnosis for patients.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Adriana Hepner, Judith M. Versluis, Roslyn Wallace, Clara Allayous, Lauren Julia Brown, Claudia Trojanielloh, Camille Lea Gerardi, Yanina J. L. Jansenj, Prachi Bhave, Bart Neyns, Andrew Haydon, Olivier Michielin, Joanna Manganan Oliver Klein, Alexander N. Shoushtari, Allison Betof Warner, Paolo Antonio Ascierto, Jennifer Leigh McQuade, Matteo S. Carlino, Lisa Zimmer, Celeste Lebbe, Douglas B. Johnson, Shahneen Sandhu, Victoria Atkinson, Christian U. Blank, Serigne N. Lo, Georgina V. Long, Alexander M. Menzies
Summary: Acquired resistance to PD-1 therapy in melanoma is mainly oligometastatic, and patients may have a favorable survival outcome following salvage treatment.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Savannah Roy, Stephanie Lakritz, Anna R. Schreiber, Elizabeth Molina Kuna, Cathy J. Bradley, Lavanya Kondapalli, Jennifer R. Diamond
Summary: This study evaluates major adverse cardiovascular events (MACE) in older women with TNBC treated with anthracycline and taxane-based chemotherapy (ATAX) compared to taxane-based chemotherapy (TAX). The results show that ATAX does not increase the risk of MACE and there is no difference in survival between patients who received TAX and ATAX.
EUROPEAN JOURNAL OF CANCER
(2024)
Letter
Oncology
Pei-Chun Weng, Yau-Li Huang, Chun-Yu Cheng
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Philipp Jansen, Jean Le 'Clerc Arrastia, Daniel Otero Baguer, Maximilian Schmidt, Jennifer Landsberg, Joerg Wenzel, Michael Emberger, Dirk Schadendorf, Eva Hadaschik, Peter Maass, Klaus Georg Griewank
Summary: This study highlights the enormous potential of artificial intelligence in pathology, showing that it can aid in the identification of rare cutaneous adnexal tumors and potentially become a standard tool in routine diagnostics.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Casper W. F. van Eijck, Gaby Strijk, Eveline E. Vietscha, Fleur van der Sijde, Maaike Verheij, Dana A. M. Mustafa, Madelief Vinkc, Joachim G. J. V. Aerts, Casper H. J. van Eijck, Marcella Willemsen
Summary: The study reveals that FOLFIRINOX has immunomodulatory effects, suggesting its potential in immune-based combination therapies for pancreatic cancer. Additionally, certain plasma proteins hold promise as circulating predictive biomarkers for early prediction of FOLFIRINOX response in patients with pancreatic cancer.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Marwan Fakih, Chongkai Wang, Jaideep Sandhu, Jian Ye, Colt Egelston, Xiaochen Li
Summary: This study explores the impact of metastatic sites on treatment outcomes for chemotherapy-refractory colorectal cancer patients. It found that patients with liver or peritoneal metastases had poor treatment outcomes, while those with lung-only metastases showed significant response. The presence of concurrent lymph node or other extrahepatic metastatic disease diminished treatment response in patients with lung metastases. Future checkpoint inhibitor trials should stratify patients based on metastatic locations.
EUROPEAN JOURNAL OF CANCER
(2024)
Article
Oncology
Georgios Christos Tsiatsianis, Candace S. Y. Chan, Ioannis Mouratidis, Nikol Chantzi, Anna Maria Tsiatsiani, Nelson S. Yee, Apostolos Zaravinos, Verena Kantere, Ilias Georgakopoulos-Soares
Summary: The study reveals that nullpeptides can serve as biomarkers for cancer detection and treatment, particularly in highly recurrent cancer patients. These nullpeptides primarily occur in highly expressed genes, particularly in specific loci of oncogenes and tumor suppressors. Recurrent nullpeptides are more likely to be found in neoantigens, which play a significant role in immunotherapy.
EUROPEAN JOURNAL OF CANCER
(2024)